Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2012) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 10.673 Q1 | 254 | 36 | 74 | 12166 | 1847 | 74 | 25.95 | 337.94 |  |
| 2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.120 Q1 | 82 | 12 | 34 | 2387 | 151 | 34 | 3.36 | 198.92 | |
| 3 | Advances in Molecular Toxicology | book series | 0.442 Q3 | 18 | 8 | 23 | 1491 | 36 | 13 | 1.60 | 186.38 |  |
| 4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 70 | 10 | 0 | 1845 | 0 | 0 | 0.00 | 184.50 |  | |
| 5 | Pharmacology and Therapeutics | journal | 3.668 Q1 | 233 | 108 | 306 | 19821 | 3151 | 302 | 9.47 | 183.53 | |
| 6 | Medicinal Research Reviews | journal | 2.488 Q1 | 150 | 38 | 76 | 6847 | 646 | 74 | 7.59 | 180.18 | |
| 7 | Food and Drug Law Journal | journal | 0.173 Q4 | 23 | 23 | 92 | 4024 | 39 | 91 | 0.28 | 174.96 | |
| 8 | Advances in Pharmacology | journal | 2.207 Q1 | 86 | 34 | 86 | 5270 | 423 | 10 | 5.35 | 155.00 | |
| 9 | Drug Resistance Updates | journal | 3.276 Q1 | 132 | 26 | 62 | 3117 | 625 | 60 | 10.17 | 119.88 | |
| 10 | Annual Review of Pharmacology and Toxicology | journal | 10.673 Q1 | 224 | 26 | 54 | 3020 | 1334 | 54 | 24.89 | 116.15 | |
| 11 | Current Drug Metabolism | journal | 1.139 Q1 | 122 | 131 | 261 | 14321 | 1311 | 232 | 4.51 | 109.32 | |
| 12 | Cellular and Molecular Life Sciences | journal | 3.403 Q1 | 261 | 293 | 899 | 30443 | 6406 | 889 | 6.46 | 103.90 |  |
| 13 | Progress in Medicinal Chemistry | journal | 1.110 Q1 | 38 | 5 | 26 | 518 | 58 | 12 | 2.25 | 103.60 | |
| 14 | Drugs in Context | journal | 36 | 3 | 0 | 310 | 0 | 0 | 0.00 | 103.33 |  | |
| 15 | Expert Opinion on Emerging Drugs | journal | 0.898 Q2 | 54 | 44 | 137 | 4301 | 471 | 137 | 3.09 | 97.75 | |
| 16 | Journal of Experimental Pharmacology | journal | 0.121 Q4 | 23 | 2 | 1 | 192 | 0 | 1 | 0.00 | 96.00 |  |
| 17 | Neurotherapeutics | journal | 2.526 Q1 | 136 | 67 | 196 | 6383 | 1363 | 182 | 6.98 | 95.27 | |
| 18 | Issues in Toxicology | book series | 0.195 Q3 | 18 | 72 | 68 | 6768 | 52 | 64 | 0.72 | 94.00 | |
| 19 | Frontiers in Pharmacology | journal | 0.717 Q2 | 154 | 206 | 129 | 17703 | 312 | 125 | 2.42 | 85.94 | |
| 20 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.942 Q2 | 100 | 127 | 366 | 10730 | 1396 | 363 | 3.62 | 84.49 | |
| 21 | Pharmacogenomics and Personalized Medicine | journal | 0.150 Q4 | 37 | 11 | 31 | 914 | 13 | 31 | 0.55 | 83.09 | |
| 22 | Expert Opinion on Therapeutic Targets | journal | 1.788 Q1 | 106 | 138 | 337 | 11271 | 1536 | 335 | 4.36 | 81.67 | |
| 23 | Journal of International Peacekeeping | journal | 0.138 Q4 | 14 | 15 | 50 | 1222 | 21 | 47 | 0.34 | 81.47 | |
| 24 | Open Pharmacology Journal | journal | 0.201 Q3 | 6 | 5 | 10 | 400 | 11 | 10 | 1.80 | 80.00 | |
| 25 | Open Neuropsychopharmacology Journal | journal | 0.183 Q3 | 6 | 3 | 20 | 238 | 11 | 19 | 0.38 | 79.33 | |
| 26 | Expert Opinion on Therapeutic Patents | journal | 1.330 Q1 | 88 | 100 | 339 | 7922 | 1229 | 333 | 3.47 | 79.22 | |
| 27 | Expert Opinion on Investigational Drugs | journal | 1.486 Q1 | 117 | 161 | 456 | 12444 | 2063 | 446 | 4.32 | 77.29 | |
| 28 | Neuropharmacology | journal | 2.315 Q1 | 191 | 408 | 798 | 31474 | 4103 | 782 | 4.39 | 77.14 | |
| 29 | Clinical Pharmacokinetics | journal | 2.254 Q1 | 184 | 56 | 179 | 4291 | 1219 | 160 | 7.01 | 76.63 | |
| 30 | Side Effects of Drugs Annual | book series | 0.102 Q4 | 9 | 53 | 157 | 4034 | 4 | 53 | 0.02 | 76.11 | |
| 31 | Inflammation and Allergy - Drug Targets | journal | 0.973 Q2 | 55 | 66 | 153 | 4860 | 537 | 140 | 2.66 | 73.64 | |
| 32 | Future Medicinal Chemistry | journal | 1.047 Q1 | 90 | 191 | 426 | 13920 | 1083 | 338 | 2.58 | 72.88 | |
| 33 | Clinical Medicine Insights: Therapeutics | journal | 0.109 Q4 | 11 | 22 | 83 | 1600 | 14 | 83 | 0.17 | 72.73 | |
| 34 | BioDrugs | journal | 1.106 Q1 | 79 | 42 | 130 | 3053 | 546 | 127 | 3.62 | 72.69 | |
| 35 | Therapeutic Advances in Neurological Disorders | journal | 0.789 Q2 | 68 | 28 | 93 | 1970 | 302 | 89 | 4.05 | 70.36 | |
| 36 | Current Psychopharmacology | journal | 4 | 1 | 0 | 69 | 0 | 0 | 0.00 | 69.00 | | |
| 37 | Trends in Pharmacological Sciences | journal | 5.103 Q1 | 244 | 86 | 251 | 5885 | 2971 | 237 | 10.51 | 68.43 | |
| 38 | Molecular Diagnosis and Therapy | journal | 0.540 Q2 | 68 | 37 | 109 | 2509 | 237 | 102 | 1.88 | 67.81 | |
| 39 | International Journal for Parasitology: Drugs and Drug Resistance | journal | 0.638 Q2 | 47 | 32 | 4 | 2137 | 6 | 3 | 1.50 | 66.78 | |
| 40 | Journal of NeuroImmune Pharmacology | journal | 1.510 Q1 | 91 | 92 | 167 | 6131 | 735 | 158 | 3.55 | 66.64 | |
| 41 | British Journal of Pharmacology | journal | 1.811 Q1 | 244 | 556 | 1568 | 36364 | 7573 | 1499 | 5.12 | 65.40 | |
| 42 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.202 Q3 | 29 | 13 | 26 | 845 | 8 | 0 | 0.33 | 65.00 | |
| 43 | Expert Opinion on Pharmacotherapy | journal | 0.756 Q2 | 93 | 251 | 812 | 16233 | 2240 | 780 | 2.71 | 64.67 | |
| 44 | Vascular Pharmacology | journal | 1.106 Q1 | 108 | 68 | 189 | 4369 | 597 | 182 | 3.44 | 64.25 | |
| 45 | Neuropsychopharmacology | journal | 4.716 Q1 | 249 | 282 | 758 | 18037 | 6223 | 723 | 8.26 | 63.96 | |
| 46 | Journal of Psychopharmacology | journal | 1.443 Q1 | 135 | 176 | 525 | 11248 | 1996 | 489 | 3.75 | 63.91 | |
| 47 | Expert Opinion on Biological Therapy | journal | 1.247 Q1 | 102 | 183 | 429 | 11683 | 1798 | 425 | 4.17 | 63.84 | |
| 48 | Core Evidence (discontinued) | journal | 0.725 Q2 | 29 | 12 | 38 | 757 | 102 | 36 | 2.41 | 63.08 | |
| 49 | Pharmacology Biochemistry and Behavior | journal | 1.197 Q1 | 148 | 273 | 749 | 17137 | 2305 | 746 | 2.90 | 62.77 | |
| 50 | Current Cardiovascular Risk Reports | journal | 0.285 Q3 | 34 | 75 | 203 | 4704 | 107 | 201 | 0.60 | 62.72 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data